Drug intelligence / Profile preview

menthol + oxygenated glycerol triesters

Development stage
Unknown
Lead developer
NEMA Research
Modality
Small Molecules
Administration
Topical
01

Overview

Menthol + oxygenated glycerol triesters is a topical combination analgesic formulated by adding **oxygenated glycerol triesters** (also referred to as OGTs or essential oxygen oil) to a **mentholated cream**. This combination is designed to treat acute musculoskeletal pain and has been shown in a randomized, double-blind trial to provide significantly greater pain relief, improved mobility, and improved lifestyle measures compared to mentholated cream alone[1][4][5]. **Mechanism of Action:** - **Menthol**: - Activates **Transient receptor potential cation channel subfamily M member 8 (TRPM8)**, producing cooling and analgesic effects in sensory neurons[5]. - At higher concentrations, can also activate **Transient receptor potential cation channel subfamily A member 1 (TRPA1)** and **Transient receptor potential cation channel subfamily V member 3 (TRPV3)**, with variable contributions to analgesia and sensory perception[5]. - Functions as a **positive allosteric modulator** on **Gamma-aminobutyric acid A receptor (GABA-A receptor)** (producing moderate anesthetic effects), and as a **non-competitive inhibitor** of **5-hydroxytryptamine type 3 receptor (5-HT3 receptor)**[5]. - **Oxygenated glycerol triesters**: - Mechanism not clearly elucidated in publicly available studies. Described functionally as a lipid-based substance able to enhance topical analgesia and provide protective, lubricating effects to tissues. - In the context of this combination, OGTs incrementally improve pain relief and tissue comfort when added to the mentholated cream[1][6].

Other names
menthol + OGTmenthol + essential oxygen oilmentholated cream with oxygenated glycerol triesters
02

Targets

GABRR (GABA-A receptor subunit rho)TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPM8 (Transient receptor potential cation channel subfamily M member 8)HTR3A (5-hydroxytryptamine receptor 3A)GABRA2 (Gamma-aminobutyric acid receptor subunit alpha 2)TRPV3 (Transient receptor potential vanilloid subtype 3)

Beyond the preview

Go deeper on menthol + oxygenated glycerol triesters.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on menthol + oxygenated glycerol triesters.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call